Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Mantle-Cell × Irinotecan × 90 days × Clear all

Sponsor

Conditions

Colorectal Neoplasms 30 Pancreatic Neoplasms 16 Neuroblastoma 12 Neoplasm Metastasis 11 Colonic Neoplasms 10 Stomach Neoplasms 8 Rectal Neoplasms 8 Sarcoma, Ewing 6 Neoplasms 6 Rhabdomyosarcoma 5 Sarcoma 4 Esophageal Squamous Cell Carcinoma 4 Esophageal Neoplasms 4 Adenocarcinoma Of Esophagus 4 Small Cell Lung Carcinoma 3 Recurrence 3 Ovarian Neoplasms 3 Medulloblastoma 3 Lung Neoplasms 3 Ependymoma 3 Endometrial Neoplasms 3 Cholangiocarcinoma 3 Breast Neoplasms 3 Wilms Tumor 2 Uterine Cervical Neoplasms 2 Pathologic Complete Response 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Osteosarcoma 2 Kidney Neoplasms 2 Hereditary Sensory and Autonomic Neuropathies 2

Interventions

Rituximab 25 acalabrutinib 14 Cyclophosphamide 13 ibrutinib 12 venetoclax 11 zanubrutinib 9 Magnetic Resonance Spectroscopy 9 pirtobrutinib 8 obinutuzumab 8 glofitamab 8 fludarabine 8 Lenalidomide 8 CT-P10 8 Bendamustine Hydrochloride 8 Specimen Handling 7 Cytarabine 6 Biopsy 6 fludarabine phosphate 5 brexucabtagene autoleucel 4 Vincristine 4 Doxorubicin 4 Prednisone 3 Cyclosporine 3 palbociclib 2 Whole-Body Irradiation 2 Therapeutics 2 Stem Cell Transplantation 2 Mycophenolic Acid 2 Methotrexate 2 Leukapheresis 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡